- Cardiovascular safety of mirabegron in individuals treated for spinal cord injury- or multiple sclerosis-induced neurogenic detrusor overactivity2021 | First Faculty of Medicine, Third Faculty of Medicine, Central Library of Charles University
- Solifenacin Is Effective and Well Tolerated in Patients With Neurogenic Detrusor Overactivity: Results From the Double-Blind, Randomized, Active- and Placebo-Controlled SONIC Urodynamic Study2017 | First Faculty of Medicine, Third Faculty of Medicine
- Neural or "Moral" therapy in the treatment of neurogenic detrusor overactivity in multiple sclerosis patients2018 | First Faculty of Medicine
- Efficacy and safety of mirabegron for the treatment of neurogenic detrusor overactivity-Prospective, randomized, double-blind, placebo-controlled study2018 | Central Library of Charles University
- Monitoring the loss of Botulinum toxin during intradetrusor administration - pilot study results2014 | Faculty of Medicine in Hradec Králové
- Use of botulinum toxin in urology2012 | Publication without faculty affiliation
- Brain Activity on fMRI Associated With Urinary Bladder Filling in Patients with a Complete Spinal Cord Injury2017 | First Faculty of Medicine, Third Faculty of Medicine
- Final report of University Hospital Hradec Králové to the clinical trial protocol No: 191622-120Publication without faculty affiliation
- Intravesical Loss of OnabotulinumtoxinA During Endoscopic Intradetrusor Injection - A Multicenter Experience2020 | Faculty of Medicine in Hradec Králové